466 related articles for article (PubMed ID: 25853340)
1. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K
J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine of anastrozole for breast cancer: Physicochemical evaluation, in vitro cytotoxicity on BT-549 and MCF-7 cell lines and preclinical study on rat model.
Shavi GV; Nayak UY; Maliyakkal N; Deshpande PB; Raghavendra R; Kumar AR; Reddya MS; Udupa N; Shrawan B
Life Sci; 2015 Nov; 141():143-55. PubMed ID: 26423561
[TBL] [Abstract][Full Text] [Related]
3. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
4. Antibody-conjugated pH-sensitive liposomes for HER-2 positive breast cancer: development, characterization,
Raikwar S; Yadav V; Jain S; Jain SK
J Liposome Res; 2024 Jun; 34(2):239-263. PubMed ID: 37594466
[TBL] [Abstract][Full Text] [Related]
5. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
6. Evaluation the Anti-Cancer Effect of PEGylated Nano-Niosomal Gingerol, on Breast Cancer Cell lines (T47D), In-Vitro.
Behroozeh A; Mazloumi Tabrizi M; Kazemi SM; Choupani E; Kabiri N; Ilbeigi D; Heidari Nasab A; Akbarzadeh Khiyavi A; Seif Kurdi A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):645-648. PubMed ID: 29580033
[TBL] [Abstract][Full Text] [Related]
7. Anti-cancer activity of pegylated liposomal trans-anethole on breast cancer cell lines MCF-7 and T47D.
Shahbazian S; Akbarzadeh A; Torabi S; Omidi M
Biotechnol Lett; 2015 Jul; 37(7):1355-9. PubMed ID: 25792512
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
Kijima I; Itoh T; Chen S
J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
[TBL] [Abstract][Full Text] [Related]
10. Sustained release optimized formulation of anastrozole-loaded chitosan microspheres: in vitro and in vivo evaluation.
Shavi GV; Nayak UY; Reddy MS; Karthik A; Deshpande PB; Kumar AR; Udupa N
J Mater Sci Mater Med; 2011 Apr; 22(4):865-78. PubMed ID: 21431353
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy.
Ghafari M; Haghiralsadat F; Khanamani Falahati-Pour S; Zavar Reza J
J Cell Biochem; 2020 Jul; 121(7):3584-3592. PubMed ID: 31907989
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent.
Parise A; Milelli A; Tumiatti V; Minarini A; Neviani P; Zuccari G
Drug Deliv; 2015; 22(5):590-7. PubMed ID: 24286206
[TBL] [Abstract][Full Text] [Related]
13. Silk fibroin rods for sustained delivery of breast cancer therapeutics.
Yucel T; Lovett ML; Giangregorio R; Coonahan E; Kaplan DL
Biomaterials; 2014 Oct; 35(30):8613-20. PubMed ID: 25009069
[TBL] [Abstract][Full Text] [Related]
14. Surface-modified Epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7.
Gandhi R; Khatri N; Baradia D; Vhora I; Misra A
Drug Deliv; 2016 May; 23(4):1152-62. PubMed ID: 25586675
[TBL] [Abstract][Full Text] [Related]
15. Vincristine-sulphate-loaded liposome-templated calcium phosphate nanoshell as potential tumor-targeting delivery system.
Thakkar HP; Baser AK; Parmar MP; Patel KH; Ramachandra Murthy R
J Liposome Res; 2012 Jun; 22(2):139-47. PubMed ID: 22149643
[TBL] [Abstract][Full Text] [Related]
16. PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy.
Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Fu H; Zhang Z; He Q
J Pharm Sci; 2015 Feb; 104(2):476-84. PubMed ID: 25256603
[TBL] [Abstract][Full Text] [Related]
17. Preparation, optimization, and characterization of topotecan loaded PEGylated liposomes using factorial design.
Vali AM; Toliyat T; Shafaghi B; Dadashzadeh S
Drug Dev Ind Pharm; 2008 Jan; 34(1):10-23. PubMed ID: 18214751
[TBL] [Abstract][Full Text] [Related]
18. Design and development of PEGylated liposomal formulation of HER2 blocker Lapatinib for enhanced anticancer activity and diminished cardiotoxicity.
Shrivastava R; Trivedi S; Singh PK; Asif M; Chourasia MK; Khanna A; Bhadauria S
Biochem Biophys Res Commun; 2018 Sep; 503(2):677-683. PubMed ID: 29908185
[TBL] [Abstract][Full Text] [Related]
19. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.
Gabizon AA; Tzemach D; Horowitz AT; Shmeeda H; Yeh J; Zalipsky S
Clin Cancer Res; 2006 Mar; 12(6):1913-20. PubMed ID: 16551877
[TBL] [Abstract][Full Text] [Related]
20. The Role of Polyethylene Glycol Size in Chemical Spectra, Cytotoxicity, and Release of PEGylated Nanoliposomal Cisplatin.
Shirzad M; Jamehbozorgi S; Akbarzadeh I; Aghabozorg HR; Amini A
Assay Drug Dev Technol; 2019 Jul; 17(5):231-239. PubMed ID: 31081680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]